Consultation record
Submissions noted, no amendment — page 2
The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Submissions
127 documents · page 2 of 5
Table 1. Submissions with this disposition, on this page.
| Reference | Consultation | Respondent | Point raised |
|---|---|---|---|
| DRAFT-PEOPLE-REGIS/002 | Draft policy on the register of members and reviewers | Dr Zofia Petrossian industry | The disclosure requirements exceed those of comparable bodies |
| DRAFT-CORRECTIONS-/011 | Draft corrections and versioning policy | Rosalind Petrossian | A sortable table implies a comparison the underlying data do not support |
| DRAFT-STABILITY-ST/006 | Draft standard: freeze–thaw and in-use stability assessment of… | Dr Ngozi Zetterlund | A superseded version should remain reachable from the version that replaced it |
| DRAFT-INDICATION-S/003 | Draft indication set and anchor outcomes | Dr Ludmila Castellanos-Reid | A superseded version should remain reachable from the version that replaced it |
| DRAFT-INDICATION-S/005 | Draft indication set and anchor outcomes | Dr Liesbeth Delacroix-Njoku | Declared interests should appear on the document rather than on a separate page |
| DRAFT-INDICATION-S/008 | Draft indication set and anchor outcomes | Dr Quentin Whitmarsh-Obi | A sortable table implies a comparison the underlying data do not support |
| DRAFT-MASH-SYNTHES/003 | Draft synthesis: incretin receptor agonists for metabolic… | Dr Mordecai Bellingham-Ojo | A sortable table implies a comparison the underlying data do not support |
| DRAFT-ADOLESCENT-S/006 | Draft synthesis: incretin receptor agonists in adolescents | Dr Thaddeus Isaksen-Balogun | A sortable table implies a comparison the underlying data do not support |
| DRAFT-ADOLESCENT-S/005 | Draft synthesis: incretin receptor agonists in adolescents | Dr Melisande Kirkpatrick-Ola | Declared interests should appear on the document rather than on a separate page |
| DRAFT-ANALYTICAL-S/014 | Draft analytical review: surveys of unregulated peptide supply | Dr Séverine Oduya-Kaltenbrunner | A sortable table implies a comparison the underlying data do not support |
| DRAFT-REGISTRY-STR/004 | Draft structure of the document registry | Dr Mordecai Glendinning-Uche | A superseded version should remain reachable from the version that replaced it |
| DRAFT-TOOLS-DISCLA/015 | Draft terms for the Institute’s calculators | Dr Rukayat Zaleski-Mbeki | The Institute publishes no telephone number and no messaging channel |
| DRAFT-TOOLS-DISCLA/010 | Draft terms for the Institute’s calculators | Ms Rhiannon Okoye-Vandergraaf | A sortable table implies a comparison the underlying data do not support |
| DRAFT-TOOLS-DISCLA/012 | Draft terms for the Institute’s calculators | Dr Xenia Uttridge industry | The disclosure requirements exceed those of comparable bodies |
| DRAFT-TOOLS-DISCLA/005 | Draft terms for the Institute’s calculators | Leonhard Achterberg | Declared interests should appear on the document rather than on a separate page |
| DRAFT-TOOLS-DISCLA/011 | Draft terms for the Institute’s calculators | Dr Nadezhda Lavrentiev | A superseded version should remain reachable from the version that replaced it |
| DRAFT-ORFORGLIPRON/005 | Draft monograph: orforglipron | Dr Melisande Kirkpatrick-Ola | Declared interests should appear on the document rather than on a separate page |
| DRAFT-METHODOLOGY-/019 | Draft methodology document, version 4 | Dr Hyacinth Oyelaran-Steen | A superseded version should remain reachable from the version that replaced it |
| DRAFT-METHODOLOGY-/003 | Draft methodology document, version 4 | Dr Theodora Ximenes | A superseded version should remain reachable from the version that replaced it |
| DRAFT-METHODOLOGY-/007 | Draft methodology document, version 4 | Dr Marisol Dunmore-Ekpo | A sortable table implies a comparison the underlying data do not support |
| DRAFT-METHODOLOGY-/011 | Draft methodology document, version 4 | Rosalind Petrossian | Declared interests should appear on the document rather than on a separate page |
| DRAFT-SUPPLIERS-CO/006 | Draft supplier comparison table | Dr Prosper Vercingetorix | Declared interests should appear on the document rather than on a separate page |
| DRAFT-SUPPLIERS-CO/009 | Draft supplier comparison table | Dr Ngozi Zetterlund | A superseded version should remain reachable from the version that replaced it |
| DRAFT-RETATRUTIDE-/005 | Draft monograph: retatrutide | Dr Lorcan Zaleski-Mbeki | Declared interests should appear on the document rather than on a separate page |
| DRAFT-RETATRUTIDE-/004 | Draft monograph: retatrutide | Yusuf Whitmarsh-Obi | Guidance on lyophilised storage is missing |
| DRAFT-MELANOCORTIN/007 | Draft scoping review: melanocortin receptor agonists | Dr Rukayat Zaleski-Mbeki | Baseline imbalance in a small contributing trial is not remarked on |
| DRAFT-SEARCH-STRAT/004 | Draft search-strategy template for the synthesis series | Zdenka Ximenes | The document should describe how an assessment becomes a decision |
| DRAFT-SEARCH-STRAT/009 | Draft search-strategy template for the synthesis series | Ignatius Erlingsson | Declared interests should appear on the document rather than on a separate page |
| DRAFT-SEARCH-STRAT/015 | Draft search-strategy template for the synthesis series | Dr Zdenka Nyquist-Obiora | A superseded version should remain reachable from the version that replaced it |
| DRAFT-PRINT-AND-AR/002 | Draft print and archival format for Institute documents | Dr Leonhard Quenneville | Declared interests should appear on the document rather than on a separate page |
page 2 of 5